[1]
Josefsson, A. et al. 2023. Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14). Acta Oncologica. 62, 4 (Apr. 2023), 372–380. DOI:https://doi.org/10.1080/0284186X.2023.2199940.